Wound treatment with human skin equivalent

Journal of the American Podiatric Medical Association

Volumn 92, Issue 1, 2002, Pages 19-23

  De, Sumit K ^b   Reis, Ernane D ^a   Kerstein, Morris D ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ARTIFICIAL SKIN; AUTOTRANSPLANTATION; CHRONIC DISEASE; COMPARATIVE STUDY; GRAFT SURVIVAL; HUMAN; INJURY; METHODOLOGY; PHYSIOLOGY; PODIATRY; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SKIN TRANSPLANTATION; WOUND HEALING;

CHRONIC DISEASE; GRAFT SURVIVAL; HUMANS; PODIATRY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 0036357543     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/87507315-92-1-19     Document Type: Review

References (32)

1. TRENT JF, KIRSNER RS: Tissue engineered skin: Apligraf, a bi-layered living skin equivalent. Int J Clin Pract 56: 408, 1998.
2. PARENTEAU NL, BILBO P, NOLTE CJ, ET AL: The organotypic culture of human skin keratinocytes and fibroblasts to achieve form and function. Cytotechnology 9: 163, 1992.
3. SABOLINSKI ML, ALVAREZ O, AULETTA M, ET AL: Cultured skin as a "smart material" for healing wounds: experience in venous ulcers. Biomaterials 17: 311, 1996.
4. MARTIN P: Wound healing: aiming for perfect skin regeneration. Science 276: 75, 1997.
5. KERSTEIN MD: The scientific basis of healing. Adv Wound Care 10: 30, 1997.
6. LAZARUS GS, COOPER DM, KNIGHTON DR, ET AL: Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 130: 489, 1994.
7. CORNWALL JV, DORE CJ, LEWIS JD: Leg ulcers: epidemiology and aetiology. Br J Surg 73: 693, 1986.
8. NANGIA A, GAMBHIR R, MAIBACH H: Factors influencing the performance of temporary skin substitutes. Clin Mater 7: 3, 1991.
9. TARLTON JF, BAILEY AJ, CRAWFORD E, ET AL: Prognostic value of markers of collagen remodeling in venous ulcers. Wound Repair Regen 7: 347, 1999.
10. FALANGA V, MARGOLIS D, ALVAREZ O, ET AL: Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent: human skin equivalent investigators group. Arch Dermatol 134: 293, 1998.
11. AUGER FA, ROUABHIA M, GOULET F, ET AL: Tissue-engineered human skin substitutes developed from collagen-populated hydrated gels: clinical and fundamental applications. Med Biol Eng Comput 36: 801, 1998.
12. LAING P: The development and complications of diabetic foot ulcers. Am J Surg 176 (suppl 2A): 11S, 1998.
13. KATZ AB, TAICHMAN LB: Epidermis as a secretory tissue: an in vitro tissue model to study keratinocyte secretion. J Invest Dermatol 102: 55, 1994.
14. FALANGA V: Apligraf treatment of venous ulcers and other chronic wounds. J Dermatol 25: 812, 1998.
15. ANGLE N, BERGAN JJ: Chronic venous ulcer. BMJ 314: 1019, 1997.
16. ALLMAN RM: Pressure ulcer prevalence, incidence, risk factors, and impact. Clin Geriatr Med 13: 421, 1997.
17. ALLMAN RM: Outcomes in prospective studies and clinical trials. Adv Wound Care 8 (suppl): 61, 1995.
18. BREM H, BALLEDUX J, BLOOM T, ET AL: Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. Arch Surg 135: 627, 2000.
19. RATLIFF CR, RODEHEAVER GT: Pressure ulcer assessment and management. Lippincotts Prim Care Pract 3: 242, 1999.
20. DEFLOOR T: The risk of pressure sores: a conceptual scheme. J Clin Nurs 8: 206, 1999.
21. DOLYNCHUK K, HULL P, GUENTHER L, ET AL: The role of Apligraf in the treatment of venous leg ulcers. Ostomy Wound Manage 45: 34, 1999.
22. NELZEN O, BERGQVIST D, LINDHAGEN A, ET AL: Chronic leg ulcers: an underestimated problem in primary health care among elderly patients. J Epidemiol Community Health 45: 184, 1991.
23. BOULTON AJ, MENESES P, ENNIS WJ: Diabetic foot ulcers: a framework for prevention and care. Wound Rep Reg 7: 7, 1999.
24. DANIELS TR: Diabetic foot ulcerations: an overview. Ostomy Wound Manage 44: 76, 1998.
25. LEVIN M: Diabetic foot wounds: pathogenesis and management. Adv Wound Care 10: 24, 1997.
26. PHAM HT, ROSENBLUM BI, LYONS TE, ET AL: Evaluation of a human skin equivalent for the treatment of diabetic foot ulcers in a prospective, randomized, clinical trial. Wounds 11: 79, 1999.
27. LANGEMO DK: Venous ulcers: etiology and care of patients treated with human skin equivalent grafts. J Vasc Nurs 17: 6, 1999.
28. RUDOLPH DM: Pathophysiology and management of venous ulcers. J Wound Ostomy Continence Nurs 25: 248, 1998.
29. BLACK SB: Venous stasis ulcers: a review. Ostomy Wound Manage 41: 20, 1995.
30. FITZPATRICK JE: Stasis ulcers: update on a common geriatric problem. Geriatrics 44: 19, 1989.
31. EAGLSTEIN W, IRIONDO M, LASZLO K: A composite skin substitute (graftskin) for surgical wounds: a clinical experience. Dermatol Surg 21: 839, 1995.
32. KNIGHT EV, OLDHAM JW, MOHLER, MA, ET AL: A review of nonclinical toxicology studies of becaplermin (rhPDGF-BB). Am J Surg 176 (suppl 2A): 55S, 1998.